Welcome to the Walter and Eliza Hall Institute of Medical Research
With the NDDC researchers have access to advanced high-throughput screening and the latest robotic technologies in a fully staffed facility.
Apply for an Australian government-subsidised screening campaign, and fast track your discoveries into new medicines.
RethiNKing which immune cells are the best weapon against lung cancer
Immune cells called ‘natural killer’ (NK) cells could be a powerful weapon for fighting lung cancer, according to Melbourne researchers.
Search for COVID-19 drugs boosted by SARS discovery
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
Lockdowns have economic and social costs for world’s poorest families
Low socioeconomic families – and particularly women – experienced increased financial hardship, food insecurity, domestic violence and mental health challenges during COVID-19 lockdown measures in Bangladesh, a new research study shows.
Iron study combats anaemia with cutting-edge computer simulation
A new iron intervention study has determined which of the world’s low-and-middle income countries would benefit from using iron-containing micronutrient powders to tackle childhood anaemia.
Wednesday seminar series hosted by Associate Professor Peter Czabotar
Associate Professor Matthew Call, Division Head, Structural Biology division - New Medicines & Advanced Technologies Theme
"Natural and engineered receptors in cancer development and treatment"
Join via TEAMS
Including Q&A session
Is it possible to move from postdoc to CEO? Dean did!
Impact and startups are not limited to professor-level researchers, so we're here to get insights and inspiration from CEO of Seer Medical, Dr Dean Freestone.
What advice does Dean have for other researchers who want to make impact in this way?
Register now and join this great conversation
Just six years after his PhD, Dean co-founded Seer Medical with Professor Mark Cook and George Kenley, a digital health company enabling epilepsy diagnostics in the comfort of home.
An engineer by training, Dean's work now lies at the intersection of machine learning, medical devices, neural modelling, and electronic engineering.
Dr Markey is a Brisbane-trained physician-scientist who is currently junior faculty on the BMT service at Memorial Sloan Kettering, New York. Her research program is focused on the intersection between transplant immunology and the microbiome. Her talk will review recent findings from the group at MSKCC, discuss recent cGVHD/microbiota findings in more detail, and share some preliminary pre-clinical data regarding the role of microbe-derived short chain fatty acids in alloreactivity.
Zoom link: https://unimelb.zoom.us/j/92308439362
Contact: le.k@wehi.edu.au by 11am on 20 October for password access number
Empty
